Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience

Published Online: May 01, 2003
Darren Kocs, MD, MHSA; A. Mark Fendrick, MDS


PDF
Feature
Recommended Articles
VSEO N/A